BioAdvance is venture capital firm specializing in pre seed, seed, and start up investments. The firm seeks to invest in life sciences, therapeutic agents, diagnostics, health information technology, medical devices, research tools, and platform technologies focused on human health. It prefers to invest in Mid-Atlantic companies mainly based in the Southeastern region of Pennsylvania in the United States. The firm makes a maximum of $0.5 million equity investment. BioAdvance was founded in 2002 and is based in Radnor, Pennsylvania.

BioAdvance

Partner

Director

Program Director

Advisor and Former CEO

MD and CEO

Director of Finance

Avid Radiopharmaceuticals raised $500000 on 2005-01-25 in Seed Round

Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.

Avid Radiopharmaceuticals

Phrase Health raised $3000000 on 2021-10-28 in Seed Round

Phrase Health, Inc. provides software solutions for health care sector. The company was founded in 2018 and is based in Philadelphia, Pennsylvania.

Phrase Health

Halo Labs raised an undisclosed amount on 2011-04-15 in Seed Round

Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics.

Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.

Halo Labs

Niiki Pharma raised an undisclosed amount on 2010-09-01 in Venture Round

Niiki Pharma is a development focused oncology company specializing in first-in-class cancer treatments directed at novel cellular targets and related companion diagnostics. With a team of experts in cancer drug development and commercialization, Niiki Pharma programs are characterized by quality, speed and capital efficient processes.

Niiki Pharma

RiboNova raised an undisclosed amount on 2016-02-23 in Seed Round

RiboNova is a biomedical research company in the Lankenau Institute for Medical Research.

The company develops a small molecule drugs against a new family of targets, defective transfer RNAs. Its focus is on novel therapies for the treatment of serious rare diseases, including mitochondrial disease and certain cancers.

RiboNova

Mebias Discovery raised an undisclosed amount on 2016-09-23 in Venture Round

Mebias Discovery, LLC discovers and progresses pathway selective GPCR drugs. It offers GPCR targets for neurodegenerative disorders, mood disorders, pain (non-opioid), cardiovascular, and immuno-oncology. The company was incorporated in 2015 and is based in Philadelphia, Pennsylvania.

Mebias Discovery, LLC

Acuity Pharmaceuticals raised $15000000 on 2004-10-07 in Series B

Acuity Pharmaceuticals is a pharmaceutical company that is focused on the treatment and prevention of ophthalmic diseases. It develops treatments for age-related macular degeneration and diabetic retinopathy. The company offers Cand5, a clinical compound that is able to shut down vascular endothelial growth factor.

Acuity Pharmaceuticals was acquired by OPKO Health in June 2011.

Acuity Pharmaceuticals was founded in 2007 and is based in Philadelphia, Pennsylvania.

Acuity Pharmaceuticals

Ride Health raised $6200000 on 2020-01-07 in Series A

Ride Health LLC develops a SaaS product platform which enables healthcare providers to schedule, request, and pay for rides on behalf of patients to and from medical appointments. The platform allows coordinators to schedule patient rides in advance or on-demand, sends text message updates and reminders to patients throughout the process, and gives coordinators real-time insight on transportation costs and usage. Ride Health LLC was founded in 2016 and is based in New York, New York.

Ride Health LLC

Palvella Therapeutics raised $45000000 on 2020-05-28 in Series C

Palvella Therapeutics is a start-up life sciences company that focuses on relentlessly and selflessly serving abandoned patient populations with therapies. The company specializes in developing therapies that specifically target the root cause of the disease.

Palvella Therapeutics was founded in 2015 and headquartered in Wayne, Pennsylvania.

Palvella Therapeutics

Formae raised an undisclosed amount on 2008-07-08 in Seed Round

Formae, Inc. develops products in arthroscopic joint resurfacing and replacement. It offers ArthroPad, a biocompatible implant offering an arthroscopic minimally invasive surgical option to replace damaged cartilage in arthritic joints. The company serves applications, such as arthritis and joint destructions. Formae, Inc. was founded in 2006 and is based in Paoli, Pennsylvania.

Formae

Cohero Health raised an undisclosed amount on 2016-06-10 in Venture Round

Cohero Health offers a proprietary connected health platform for those with respiratory illness. Its sensor-based technology and engaging platform improve medication adherence and care coordination between patients and their care providers.

The company offers a suite of tools and technology comprises form flexible inhaler sensors, mobile spirometers, to track real-time adherence and lung function, and a mobile application accessible on iPhone, iWatch, and Android. 

Cohero Health was founded in 2013 and is headquartered in New York.

Cohero Health

InfraScan raised an undisclosed amount on 2008-11-18 in Seed Round

InfraScan, Inc., a medical device company, develops, commercializes, and distributes hand-held diagnostic devices for head injury and stroke assessment based on near-infrared (NIR) technology. It offers Infrascanner, a diagnostic device that enables clinicians to detect intracranial bleeding in patients with head trauma; and education and training services. The company’s device is used in hospital and intensive care monitoring, military, screening in remote areas, sports medicine, pediatrics, ambulance services, and other applications. It sells its products through distributors in North America, South America, Africa, Asia, the Middle East, and Europe. InfraScan, Inc. was incorporated in 2004 and is based in Philadelphia, Pennsylvania with research and development lab in Philadelphia, Pennsylvania.

InfraScan

Bainbridge Health raised $1600000 on 2018-06-15 in Seed Round

Bainbridge Health provides hospital systems with a clinical intelligence and data analytics platform to improve medication safety. It provides hospital safety professionals with an infusion pump management software solution to better manage pump data and enhance patient safety. Bainbridge Health also offers a clinician-focused infusion pump management system known as InfusionWare that enables clinicians to manage infusion data in one centralized location.

Bainbridge Health

Phoenix S&T raised an undisclosed amount on 2008-03-21 in Seed Round

Phoenix S&T, Inc. designs, develops, and supplies nanospray and microspray systems for life research and drug discovery solutions. The company’s Nimbus and pneu-Nimbus NanoLC systems provide ionization for LC/MS experiments; clinical diagnostics; and homeland security. It offers column haters, column coolers, and emitters and columns. The company’s products are used in various applications, including proteomics, biomarkers, and direct infusion. It serves customers in Europe and China. The company was founded in 2001 and is based in Chadds Ford, Pennsylvania.

Phoenix S&T, Inc.

Ceptaris Therapeutics raised $4500001 on 2006-11-14 in Series B

Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If approved, Ceptaris' investigational drug would be the first topical mechlorethamine product available to treat the signs and symptoms of this rare cancer.

Ceptaris Therapeutics

Marillion Pharmaceuticals raised an undisclosed amount on 2007-05-01 in Venture Round

Marillion Pharmaceuticals Inc. develops and commercializes pharmaceuticals and therapeutics for the treatment of cancers, inflammatory, and autoimmune diseases.

Marillion Pharmaceuticals

Niiki Pharma raised an undisclosed amount on 2012-12-03 in Venture Round

Novira Therapeutics raised an undisclosed amount on 2009-01-28 in Seed Round

Novira Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops antiviral drugs for the treatment of chronic hepatitis B infection. It develops core and cccDNA inhibitor anti-HBV drugs. Novira Therapeutics, Inc. was formerly known as Molecmo Nanobiotechnologies, Inc. The company was incorporated in 2006 and is based in Doylestown, Pennsylvania. As of December 4, 2015, Novira Therapeutics, Inc. operates as a subsidiary of Johnson & Johnson.

Novira Therapeutics, Inc.

Jenrin Discovery raised an undisclosed amount on 2010-01-08 in Venture Round

Jenrin Discovery, Inc., a pharmaceutical company, develops small molecule drugs and therapeutics targeting peripheral tissues for various chronic diseases. It develops peripherally selective agents in variety of therapeutic areas, such as diabetes, NAFLD/NASH, obesity, autoimmune/inflammatory disorders, and malaria. The company was founded in 2004 and is based in Philadelphia, Pennsylvania.

Jenrin Discovery, Inc.

EyeIC raised an undisclosed amount on 2005-05-04 in Seed Round

EyeIC, Inc. develops and commercializes imaging technologies for medical applications. The company serves eye care professionals and eye clinics. It offers MatchedFlicker, a device for monitoring the advent and progression of glaucoma through change detection in time series retinal photographs. The company's software works by aligning and registering two images of the same object taken at different points in time, and then generating a superimposed view that is alternated back and forth. The company was founded in 2004 and is based in Wayne, Pennsylvania.

EyeIC, Inc.

Halo Labs raised $6000000 on 2022-07-11 in Series C

Opsidio raised $500000 on 2017-09-25 in Venture Round

A biotech company, engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company was founded in 2012 and is headquartered in Bryn Mawr, Pennsylvania .

Opsidio

Noble.MD raised $1450000 on 2016-05-17 in Seed Round

Noble.MD develops Theo, a digital healthcare advisory platform that helps patients to identify health and behavioral risks, and activate patients to manage those risks through programs and interventions. The company’s platform captures patient data required for value-based reimbursement at the time-of-care; and aligns provider and payer interests to accelerate risk identification, coding, and management. Noble.MD was founded in 2012 and is based in Bryn Mawr, Pennsylvania.

Noble.MD

KayoThera raised $8000000 on 2022-03-16 in Series A

KayoThera is a biotechnology company developing therapeutics used to cure late-stage and metastatic cancers. Its programs work on inhibiting a key enzyme that is responsible for protecting the cancer cells and depleting regulatory T-cells that intends to cure hitherto incurable cancers and give hope to patients. The company's mission is to develop the first-in-class immuno- and targeted therapies to drive cures in advanced cancers

KayoThera was founded in 2019 and is headquartered in Princeton, New Jersey.

KayoThera

Novira Therapeutics raised an undisclosed amount on 2010-09-30 in Seed Round

Halo Labs raised $5600000 on 2018-12-20 in Series B

Jenrin Discovery raised an undisclosed amount on 2014-09-11 in Venture Round

Merganser Biotech raised an undisclosed amount on 2014-01-21 in Series A

Merganser Biotech is a research company that is engaged in the development and licensing of medicines for the treatment of hematological and iron overload diseases that include beta thalassemia and hemochromatosis. The company develops hepcidin mimetic peptides to control iron metabolism and ineffective erythropoiesis.

Merganser Biotech was founded 2011 and is based in Newtown Square, Pennsylvania.

Merganser Biotech

Alteris Therapeutics raised an undisclosed amount on 2003-07-02 in Seed Round

Alteris Therapeutics, Inc. engages in the discovery and development of therapeutics and vaccines based on alternative gene splice forms for the treatment of cancer. Its compound, ALT-110, a therapeutic vaccine against the splice variant growth factor EGFRvIII, is currently being tested in a Phase I cancer trial. The company also has a drug discovery program, which targets tumors, including breast, colon, lung, ovarian, and central nervous system cancers. Alteris Therapeutics, formerly known as Spliceomix, Inc., was founded in 2002 and is based in Philadelphia, Pennsylvania. As of October 12, 2005, Alteris Therapeutics Inc. is a subsidiary of Celldex Therapeutics Inc.

Alteris Therapeutics Inc.

Wellsheet raised $2290000 on 2017-08-22 in Seed Round

Wellsheet organizes clinical information with machine learning to predict and visualize the most relevant information for patient care in a physician-friendly format within the existing EHR (Electronic Health Record). By allowing providers to arrive at clinical insights faster, Wellsheet improves early intervention and hospital efficiency, with proven impact in a 10,000 physician health system in NJ. Wellsheet has partnered with major EHR vendors including Epic and Cerner to distribute the Wellsheet product through SaaS-based model for health system customers.

WellSheet, Inc.

Ceptaris Therapeutics raised $2000000 on 2010-11-23 in Debt Financing

Cira Discovery Sciences raised an undisclosed amount on 2004-01-28 in Seed Round

Cira Discovery Sciences creates new advanced algorithmic methods for analyzing High Dimensional Biology. The increasing availability of high-quality data from "-omics" methodologies represents an opportunity to create value for Life Sciences enterprises.

Cira Discovery Sciences

HealthQx raised $3657000 on 2015-04-07 in Series B

HealthQX specializes in Value-based Payment (VBP) analytic software solutions for health plans and providers. Its VBP analytics platform, ClarityQx, provides the capabilities to design, implement, and monitor the on-going performance of payment models such as episodic, bundled, or accountable care arrangements.

The company was founded in 2012 and is based in King Of Prussia, Pennsylvania.

HealthQx

Life Mist Technologies raised an undisclosed amount on 2013-01-18 in Seed Round

Life Mist Technologies, Inc., doing business as LMT, develops and commercializes an atomization technology that uses low pressure gas and liquid to produce a high volume of micron sized droplets. The company focuses on using its technology in various industrial applications, such as aircraft fire suppression, chemical processing, emission control, fire suppression, decontamination, turbine inlet cooling, artificial snow, and cooling. Life Mist Technologies was incorporated in 2004 and is based in Paoli, Pennsylvania.

Life Mist Technologies

PhenoTech raised an undisclosed amount on 2004-03-19 in Seed Round

PhenoTech a biotechnology company, engages in the discovery, development, and commercialization of reagents for diagnostic use in blood banks. The company offers blood diagnostic reagents, such as Nanoscale Emissive Antibody-complexes for Typing reagents for pre-transfusion testing. It also provides therapeutic agents, including a series of human-like monoclonal antibodies for treatment of Idiopathic Thrombocytopenic Purpura, an autoimmune disorder in the field of hematology; and anti-platelet agents, such as Infusable gpIIb/IIIa antagonist agents that are used after acute myocardial infarction, as well as in patients undergoing balloon angioplasty or stent placement in order to prevent cardiac ischemic complications.

PhenoTech, Inc.

Enzium raised an undisclosed amount on 2016-07-06 in Venture Round

Enzium is dedicated to developing fluorescent based reagents for highly selective protease activity detection using their proprietary modular protein and dye technology. Their technology allows us to quickly swap out protein modules, much like legos, to easily build new, selective assay reagents. It is their goal to enable their customers to integrate the same reagent kit/assay in applications across entire research, drug, and diagnostic development pipelines.

Enzium, Inc.

Phrase Health raised an undisclosed amount on 2019-01-01 in Pre Seed Round

Novira Therapeutics raised an undisclosed amount on 2010-01-04 in Venture Round

Immunome raised $467500 on 2014-10-14 in Venture Round

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery. It features a software platform that enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens.

Immunome

Cool-Bio raised an undisclosed amount on 2012-05-01 in Seed Round

COOL~BIO is a biotechnology company focused on developing hypothermia-activated biologics. Therapeutic hypothermia (TH) is the process of cooling the body to prevent organ damage and is widely-used in cardiac surgery, ischemic stroke, cardiac arrest, neurosurgery and traumatic brain injury. Their lead molecule is an anti-platelet agent being developed for use during cardiopulmonary bypass.

Cool-Bio

NuPathe raised $15000000 on 2006-09-12 in Series A

NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for neurological and psychiatric disorders. The company’s lead product is Zecuity, which is a sumatriptan iontophoretic transdermal system used for the acute treatment of migraine with or without aura in adults. Its pipeline product candidates include NP201 for the continuous symptomatic treatment of Parkinson's disease; and NP202 for the long-term treatment of schizophrenia and bipolar disorder. The company develops its products using SmartRelief, a proprietary transdermal medication delivery technology based on iontophoresis, a non-invasive method of actively transporting molecules, such as sumatriptan; and Long-Acting Delivery, a biodegradable polymer matrix, which uses medical polymers and an active drug combined to form a small implant for injection just below the skin. NuPathe Inc. was founded in 2005 and is based in Malvern, Pennsylvania. As of February 20, 2014, NuPathe, Inc. operates as a subsidiary of Teva Pharmaceutical Industries Limited.

NuPathe, Inc.

Venatorx Pharmaceuticals raised $3419051 on 2013-12-04 in Venture Round

VenatoRx Pharmaceuticals, Inc., a pharmaceutical company, discovers and develops anti-infective agents. The company provides various antibacterial agents. It focuses on addressing resistant hospital and community bacterial infections, including difficult-to-treat infections caused by MRSA, Pseudomonas spp, and Salmonella spp. The company was founded in 2010 and is based in Malvern, Pennsylvania.

VenatoRx Pharmaceuticals, Inc.

InfraScan raised $500000 on 2005-10-05 in Seed Round

Cira Discovery Sciences raised an undisclosed amount on 2004-12-28 in Seed Round

Cytovas raised an undisclosed amount on 2017-08-14 in Venture Round

CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The company's platforms include CLOUD CYTOMICS and CytoVas Vascular Health Profile. CLOUD CYTOMICS provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was incorporated in 2010 and is headquartered in Philadelphia, Pennsylvania.

Cytovas

Jenrin Discovery raised an undisclosed amount on 2016-09-16 in Venture Round

Niiki Pharma raised an undisclosed amount on 2011-10-12 in Venture Round

Midway Pharmaceuticals raised $500000 on 2006-04-17 in Seed Round

Midway Pharmaceuticals is a developer of specialty drugs designed to provide beneficial effects in the treatment of gastrointestinal and systemic diseases. The company's specialty drugs focus on finding high molecular weight polymers that can be consumed orally and inhibit the pathogenic behavior of bacteria in the GI tract, enhance gut barrier function and promote gastrointestinal healing, enabling healthcare institutions to avail enhanced drugs to protect people's guts from radiation damage and infection.

Midway Pharmaceuticals

Innovative Supply Solutions raised an undisclosed amount on 2012-11-01 in Venture Round

Innovative Supply Solutions LLC, a specialty contract service organization, provides clinical drug supply chain management services. Its services include planning/forecasting for API/formulated product needs, project management, budget projection/management, packaging design, inventory management, supply chain coordination and management, IVR/IWR supply design and management, manufacturing coordination, packaging and labeling coordination, distribution coordination, analytical services coordination, product sourcing, material destruction coordination, and consultancy. The company is based in Southampton, Pennsylvania.

Innovative Supply Solutions

Penn-Greene raised an undisclosed amount on 2011-09-06 in Seed Round

Penn-Greene

Immunome raised $7200000 on 2016-10-06 in Series A

Ceptaris Therapeutics raised an undisclosed amount on 2010-10-12 in Venture Round

Genome Profiling raised $880000 on 2017-08-14 in Venture Round

Genome Profiling, LLC, a bioinformatics company, engages in the discovery of novel epigenetic biomarkers for treating diagnosing, and predicting chronic and life-threatening diseases. It offers GenPro Analytics, a software platform to discover novel epigenetic biomarkers that scientists and medical professionals use to predict, diagnose, and monitor the likelihood and progression of disease in individuals with more sensitivity, specificity, accuracy, and cost-effectiveness. The company was incorporated in 2012 and is based in Wayne, Pennsylvania.

Genome Profiling, LLC

Galleon Pharmaceuticals raised an undisclosed amount on 2012-01-25 in Venture Round

Galleon Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and markets treatments for sleep apnea and related breathing control disorders. It offers GAL-021, a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients and patients with sleep apnea; GLN- 21,160, an oral development candidate for sleep apnea; and GAL-044, a small molecule used as a preventative medicine for surgical pain. The company was founded in 2003 and is based in Horsham, Pennsylvania.

Galleon Pharmaceuticals, Inc.

Gelifex raised an undisclosed amount on 2003-05-19 in Seed Round

Gelifex develops implants for use in relieving pain and restoring motion to patients suffering from degenerative disc disease.

Gelifex

Treventis raised an undisclosed amount on 2009-03-06 in Seed Round

TREVENTIS™ Corporation is an early stage biotechnology company focused on diseases associated with protein misfolding such as Alzheimer’s, Parkinson’s and Huntington’s.  Currently, the Company has two major areas of discovery and development including: (1) the development of drugs that halt Alzheimer’s disease (and other dementias) progression with the promise of stabilizing or improving cognition and (2) the development of companion diagnostics for detection of AD to allow for early drug intervention to minimize neuronal loss.

Treventis

Vasculab raised an undisclosed amount on 2005-03-11 in Seed Round

Vasculab is a medical device company that is looking for a consulting Design Engineer.

Vasculab

Genome Profiling raised an undisclosed amount on 2016-10-08 in Seed Round

Avid Radiopharmaceuticals raised $34500000 on 2009-05-21 in Series D

Enzium raised an undisclosed amount on 2015-04-28 in Venture Round

Treventis raised an undisclosed amount on 2012-07-30 in Seed Round

Mebias Discovery raised an undisclosed amount on 2017-02-14 in Venture Round

Ride Health raised an undisclosed amount on 2017-05-01 in Seed Round

Novira Therapeutics raised an undisclosed amount on 2010-07-06 in Venture Round

Formae raised an undisclosed amount on 2010-08-17 in Seed Round

NuPathe raised $30000000 on 2008-07-24 in Series B

Sxinos raised an undisclosed amount on 2004-06-29 in Seed Round

Sxinos Corporation is a Biotechnology company.

Sxinos

Olive Devices raised an undisclosed amount on 2017-08-14 in Venture Round

Olive Devices is an assistive device company developing smart glasses to improve communication for deaf and hard of hearing persons.

Olive Devices

SonoMedix raised an undisclosed amount on 2005-10-26 in Seed Round

SonoMedix engages in the development and commercialization of technology designed for monitoring blood coagulation and hemostatic status. The company offers Nano-Acoustic Blood Analyzer platform (NABA) technology that helps to interrogate and detect blood properties at the molecular level. This product enables healthcare workers and patients to conduct diagnostic and therapeutic monitoring at the bedside and at home, using a small hand-held device.

SonoMedix

Leversense raised $399000 on 2010-12-03 in Debt Financing

Leversense, LLC intends to develop a medical device for detecting AIDS, food toxin, and mycoplasma bacteria. The company was incorporated in 2009 and is based in Newtown Square, Pennsylvania.

Leversense

Enzium raised $750000 on 2013-05-08 in Seed Round

Jenrin Discovery raised an undisclosed amount on 2010-10-21 in Venture Round

Vindico Medical Education raised an undisclosed amount on 2008-03-19 in Seed Round

Vindico Medical Education is an accredited provider of CME, CE, and CNE multiplatform activities, offering the highest quality continuing education with the ultimate goal of improving patient health. Vindico facilitates accredited activities that positively affect clinical practice and provides quality initiatives for improving knowledge, competence, performance, and patient health.

Vindico is solely dedicated to creating educational activities that provide healthcare professionals with evidence-based education on clinical advances to improve their competence, performance-in-practice, and ultimately to better treat their patients. Vindico provides scientifically sound and evidence-based activities in a variety of core therapeutic areas including cardiology, endocrinology, hematology/oncology, infectious diseases, ophthalmology, orthopedics, and pediatrics.

Vindico employs an experienced team of physicians, scientists, educators, medical writers and editors, dedicated meeting managers, and an in-house design and recruitment department that ensure a seamless process from activity planning through delivery.

Vindico Medical Education

WellTrackONE raised $200000 on 2017-08-14 in Venture Round

WellTrackONE is a population health management company that offers an end-to-end solution to physician offices, ACOs, integrated delivery networks, hospitals, and other physician networks that helps them administer the Medicare Annual Wellness Visit to all their Medicare patients. The company provides clinical risk management services used to offer a comprehensive baseline report for detailing modifiable risk factors, preventative goals, and measurable data.

It was founded in 2012 and headquartered in Hilton Head Island, South Carolina.

WellTrackONE, LLC

Neuro Innovations raised an undisclosed amount on 2008-06-30 in Seed Round

Neuro Innovations

Halo Labs raised an undisclosed amount on 2013-11-08 in Seed Round

Immunome raised $145000 on 2012-01-04 in Seed Round

Eagle Vision Pharmaceutical raised an undisclosed amount on 2003-06-11 in Seed Round

Eagle Vision Pharmaceutical Corp. offers a novel, clinical-stage, molecular imaging opportunity that enhances the powerful potential of widely available Magnetic Resonance Imaging (MRI) to revolutionize the diagnosis and management of chronic human disease (“Magnetic PET”).

SeeMoreTM (EVP1001), a patented, first-in-class, intravenous, manganese-based, intracellular agent that targets metabolically active cells, capitalizes on the high resolution tissue discrimination of MRI to provide superior diagnostic accuracy and earlier assessment of response to therapy for improved patient management. EVP1001 distinguishes healthy from abnormal tissue in a single, noninvasive exam that avoids radiation and radioactive agents. Preclinical and clinical results have validated the technology for broad applications including evaluation of cancer, chronic liver disease and heart disease. Currently, a world-class medical center is conducting advanced clinical trials using EVP1001 to evaluate stem cell therapy for the heart.

Eagle Vision Pharmaceutical

Jenrin Discovery raised an undisclosed amount on 2007-04-30 in Venture Round

Niiki Pharma raised an undisclosed amount on 2008-07-29 in Seed Round

ENB Therapeutics raised $2200000 on 2018-09-20 in Series A

ENB Therapeutics, LLC develops small molecule inhibitors to treat melanoma and other cancers. The product includes ENB-001 that restores the ability of T-cells to infiltrate tumors and inhibits metastasis. The company was incorporated in 2015 and is based in New York, New York.

ENB Therapeutics, Inc.

Protez Pharmaceuticals raised an undisclosed amount on 2004-06-01 in Venture Round

Protez Pharmaceuticals is a medical research company that discovers, develops, and commercializes antibiotics for difficult-to-treat hospital-based infections. 

The company focuses on differentiated intravenous and oral small molecule antibiotics to address bacterial resistant, and chronic or recurrent infections.

Protez Pharmaceuticals was founded by Christopher M. Cashman in 2003 and is headquartered in Malvern, Pennsylvania.

Protez Pharmaceuticals

Phoenix S&T raised $50000 on 2010-07-07 in Debt Financing

Melior Discovery raised $500000 on 2005-01-25 in Seed Round

Melior Discovery, Inc. develops an in vivo pharmacology platform that identifies novel indications from pre-clinical and development-stage candidates. The company offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal and urology, cardiovascular disease, and dermatology aspects. It serves clients in pharmaceutical and biopharmaceutical industries. The company was founded in 2005 and is based in Exton, Pennsylvania.

Melior Discovery

Innovative Supply Solutions raised an undisclosed amount on 2010-04-14 in Seed Round

Acuity Pharmaceuticals raised an undisclosed amount on 2004-06-01 in Venture Round

InfraScan raised an undisclosed amount on 2005-03-16 in Seed Round